About Neurava
Neurava is a company based in West Lafayette (United States) founded in 2019 by Jay Shah and Vivek Ganesh. Neurava has raised $5.78 million across 5 funding rounds from investors including UCB, Life Science Angels and Purdue Innovates. Neurava offers products and services including Epilepsy Wearables. Neurava operates in a competitive market with competitors including Tyto Care, Endotronix, Edwards Lifesciences, CoachCare and BioIntelliSense, among others.
- Headquarter West Lafayette, United States
- Founders Jay Shah, Vivek Ganesh
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurava Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.78 M (USD)
in 5 rounds
-
Latest Funding Round
$1.6 M (USD), Seed
Oct 15, 2025
-
Investors
UCB
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurava
Neurava offers a comprehensive portfolio of products and services, including Epilepsy Wearables.
Wearables that detect epilepsy signals and alert for SUDEP risks.
Funding Insights of Neurava
Neurava has successfully raised a total of $5.78M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1.6 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $1.6M
-
First Round
First Round
(01 Jun 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Seed - Neurava | Valuation |
investors |
|
| Apr, 2024 | Amount | Seed - Neurava | Valuation | Life Science Angels | |
| Jan, 2023 | Amount | Seed - Neurava | Valuation |
investors |
|
Investors in Neurava
Neurava has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include UCB, Life Science Angels and Purdue Innovates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences startups are funded by a non-profit angel network.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in diverse sectors by the firm.
|
Founded Year | Domain | Location | |
|
Capital is invested in startups and small businesses by First Leaf Capital.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Neurava
Financial Statements - Neurava
Neurava Comparisons
Competitors of Neurava
Neurava operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Endotronix, Edwards Lifesciences, CoachCare and BioIntelliSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
Medical devices for structural heart disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Remote monitoring platform for tracking patient activity
|
|
| domain | founded_year | HQ Location |
Vital signs are monitored via a single-use patch and platform.
|
|
| domain | founded_year | HQ Location |
Developer of a wrist band to monitor physiological signals
|
Frequently Asked Questions about Neurava
Neurava was founded in 2019.
Neurava is headquartered in West Lafayette, United States. It is registered at West Lafayette, Indiana, United States.
Jay Shah is the current CEO of Neurava. They have also founded this company.
Neurava is a funded company, having raised a total of $5.78M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.24M, raised on Jun 01, 2019.
Neurava was founded in 2019 in West Lafayette, United States, focusing on health technology for epilepsy management. Operations center on remote monitoring devices that assess SUDEP risk, enable nighttime surveillance, and support expedited treatment responses. Wearable solutions and seizure alert systems are offered to patients and caregivers, with services extending to broader alert management protocols in the epilepsy sector.
Neurava's top competitors include Tyto Care, Endotronix and Empatica.
Neurava offers Epilepsy Wearables.
Neurava has 7 investors. Key investors include UCB, Life Science Angels, Purdue Innovates, Elevate Ventures, and First Leaf Capital.